
Lufthansa boss set to become new Roche chairman
pharmafile | September 16, 2013 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Chairman, Lufthansa, Roche
Roche’s board of directors are set to nominate Lufthansa chief executive Christoph Franz to be elected as its new chairman.
If his nomination is successful, he will succeed Franz Humer, who announced at the last shareholder meeting that he would not be standing for re-election.
Christoph Franz, who is currently chief executive of the Lufthansa Group, said he would not be renewing his contract with the German airline, which expires on 31 May next year.
Commenting on the nomination Roche’s current chairman Franz Humer said: “With Christoph Franz, Roche is getting a chairman with outstanding personal qualities and an impressive record as head of a major global company. I am sure that his extensive experience, exceptional global network and strong links to Switzerland will be great assets.”
Christoph Franz said: “I am delighted that the board of directors has nominated me to become the next chairman of the Roche Group. Roche is an outstanding company. As a board member I have had ample opportunity to get to know and admire its strong business performance and corporate culture. Strategically, Roche is in very good shape, and I am looking forward to taking on this opportunity.”
Related Content

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …






